This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Advances and challenges of the cell-based therapies among diabetic patients
Journal of Translational Medicine Open Access 08 May 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodgson, J. Drug pipeline 3Q23 — ERT, bispecifics and CRISPR in sickle cell disease. Nat Biotechnol 41, 1498–1500 (2023). https://doi.org/10.1038/s41587-023-02015-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-02015-z
This article is cited by
-
Advances and challenges of the cell-based therapies among diabetic patients
Journal of Translational Medicine (2024)